Trials of CRISPR/Cas9 are getting underway around the world. Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR associated protein 9, to give it its full name, holds huge promise for tackling cancer, hereditary blindness, AIDS, cystic fibrosis, Duchenne’s muscular dystrophy, hepatitis B, Huntington’s disease and even high cholesterol.
lambda - News, Features, and Slideshows
CSIRO’s head of transformational bioinformatics Denis Bauer took to the stage at an Amazon Web Services event on Wednesday to proclaim: “Once you go serverless you never go back”.
The customers around the table are gushing in their praise for Amazon CTO Werner Vogels. One puts his arm round the Dutchman’s broad shoulders to pose for a selfie: “If that’s ok? I’ve got to get one.”